Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

NANOMED2020 intends to bring more Nanomedicine products to European patients

16.10.2012
VDI/VDE-IT announced on 10th October a collaboration with key European Nanomedicine players which is funded by the European Commission.
This strong partnership of relevant stakeholders aims at identifying key areas for Nanomedicine research and at establishing novel concepts for translation of nanomedical innovations into clinical practice. The project called “NANOMED2020” started on 1st September 2012 and has duration of 18 months.

Making Europe a center for Nanomedicine research, development and translation is the goal of this project. To achieve this goal the proposed project unites partners already representing the largest network of active stakeholders in the Nanomedicine area as of today in Europe, embracing roughly 200 hundred Universities, Research Institutes, Hospitals and Public Health Institutions, Small and Medium-sized Enterprises (SMEs) and Small and Large Industry organizations.

What are the needs and the problems? Excellent academic research groups may need to better understand the market and the medical needs. There are a large number of pharmaceutical and medtech companies that have a comprehensive and direct access to market but these companies struggle to handle radical innovation. At the same time there is a small number of SMEs trying to add new innovation onto the market, but these few companies are too small to exploit the large potential of Nanomedicine. A consolidated pan-European approach to structure this field is therefore highly needed to bring Nanomedicine products more efficiently to patients.

“We are proud that we were able to receive funding for this project from the European Commission” said Dr. Sebastian Lange, the coordinator of this project at VDI/VDE-IT. “Seven renowned Nanomedicine players from six European countries hope to build a pertinent European Nanomedicine community involving all key players. We aim to define the resources, gaps and needs for development and implementation of Nanomedicine research into marketable innovations to be used by doctors for the benefit of patients.”

The NANOMED2020 project is an opportunity for all stakeholders from industry, academia, clinic and public authorities to provide the European Commission with input for a future Nanomedicine topic within Horizon 2020. This will make Nanomedicine an important contributor to the future European healthcare system with a beneficial impact on improved treatment for patients and on social challenges such as ageing population.

ABOUT NANOMED2020
The NANOMED2020 Support Action project, funded with a contribution of 500 000€ by the European Commission under the Work Programme FP7-HEALTH-2012 (Area 2012.4.1-5: Preparing the future for health research and innovation) was launched on 1st September 2012 and is planned to have duration of 18 months.
Partners of the NANOMED2020 project:

• ETP Nanomedicine c/o VDI/VDE-IT (Coordinator), http://www.etp-nanomedicine.eu
• CLINAM Foundation, http://www.clinam.org
• Instituto de Salud Carlos III, http://www.isciii.es
• Bioanalytik Muenster e.V., http://www.bioanalytik-muenster.de
• Nanobiotix, http://www.nanobiotix.com
• Fondazione Don Carlo Gnocchi ONLUS, http://www.dongnocchi.it
• SINTEF, http://www.sintef.no

For more information about the project consult: http://www.etp-nanomedicine.eu/public/news-events/news/start-of-nanomed-2020

The website www.nanomed2020.eu will be launched soon. Latest news on Nanomedicine research, strategic challenges and innovation concepts will be available there.

ABOUT Nanomedicine
Nanomedicine is understood to be the enabling instrument for personalized, targeted and regenerative medicine by delivering the next level of new drugs, treatments and implantable devices to clinicians and patients. Beyond that, Nanomedicine provides important new tools to deal with the grand challenge of an ageing population and is thought to be instrumental for improved and cost effective health-care, one crucial factor for making medicines and treatments available and affordable to all.

ABOUT ETP Nanomedicine c/o VDI/VDE-IT, http://www.etp-nanomedicine.eu, http://www.vdivde-it.de
VDI/VDE-IT is a leading service provider in the field of innovation and technology for customers in Germany and all over the world. We analyse, support and organise innovation and technology for clients with political, research, industry and finance backgrounds.

Since 2008, VDI/VDE-IT is managing the Office of the European Technology Platform on Nanomedicine, ETPN. This platform was established in 2005 as a joint venture of the European Commission and CEOs of large industrial companies such as Philips, Siemens and UCB, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for Nanomedicine research in Europe. The ETPN contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative Nanomedicines. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the EC and the European Member States.

Press contact

NANOMED2020 Coordinator
Dr. Sebastian Lange
secretariat@etp-nanomedicine.eu
+49 30 310078 155

Wiebke Ehret | idw
Further information:
http://www.etp-nanomedicine.eu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>